Memphasys receives early Thai FDA Felix approval
Memphasys' Felix System has received earlier than anticipated approval from the Thai Food and Drug Administration.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| OVN | Investor Presentation | 23/04/18 | ||
| OVN | Quarterly Business Review & Appendix 4C | PRICE SENSITIVE | 23/04/18 | |
| OVN | Change of Director's Interest Notice | 11/04/18 | ||
| OVN | Change of Director's Interest Notice | 03/04/18 | ||
| OVN | Progress Update Product Roll Out | PRICE SENSITIVE | 28/03/18 | |
| OVN | Half Yearly Report and Accounts | PRICE SENSITIVE | 27/02/18 | |
| OVN Investor Presentation | |||
| 23/04/18 | |||
| OVN Quarterly Business Review & Appendix 4C | |||
| 23/04/18 | PRICE SENSITIVE | ||
| OVN Change of Director's Interest Notice | |||
| 11/04/18 | |||
| OVN Change of Director's Interest Notice | |||
| 03/04/18 | |||
| OVN Progress Update Product Roll Out | |||
| 28/03/18 | PRICE SENSITIVE | ||
| OVN Half Yearly Report and Accounts | |||
| 27/02/18 | PRICE SENSITIVE | ||
